BVF Inc’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,064,736
| Closed | -$48.4M | – | 71 |
|
|
2023
Q3 | $48.4M | Buy |
7,064,736
+3,703,795
| +110% | +$25.4M | 1.31% | 21 |
|
|
2023
Q2 | $34.9M | Hold |
3,360,941
| – | – | 0.97% | 28 |
|
|
2023
Q1 | $27.2M | Buy |
3,360,941
+84,398
| +3% | +$683K | 0.99% | 31 |
|
|
2022
Q4 | $51.6M | Sell |
3,276,543
-700,000
| -18% | -$11M | 2.18% | 13 |
|
|
2022
Q3 | $62.6M | Hold |
3,976,543
| – | – | 2.59% | 15 |
|
|
2022
Q2 | $55.5M | Hold |
3,976,543
| – | – | 2.68% | 12 |
|
|
2022
Q1 | $68.6M | Buy |
3,976,543
+2,280,639
| +134% | +$39.3M | 2.74% | 10 |
|
|
2021
Q4 | $24.7M | Buy |
1,695,904
+322,860
| +24% | +$4.69M | 0.9% | 33 |
|
|
2021
Q3 | $24.7M | Buy |
1,373,044
+373,044
| +37% | +$6.71M | 0.96% | 28 |
|
|
2021
Q2 | $17.6M | Buy |
+1,000,000
| New | +$17.6M | 0.66% | 40 |
|